Insider Trading: Genmark Diagnostics Inc (GNMK.W)
GNMK.W on CBOE When Trading NASDAQ Global Select Market
9.80USD
19 Jun 2013
9.80USD
19 Jun 2013
Price Change (% chg)
$0.23 (+2.40%)
$0.23 (+2.40%)
Prev Close
$9.57
$9.57
Open
$9.25
$9.25
Day's High
$10.01
$10.01
Day's Low
$9.25
$9.25
Volume
1,500
1,500
Avg. Vol
759
759
52-wk High
$15.56
$15.56
52-wk Low
$4.22
$4.22
MASSARANY HANY
| Trading Date | Type | Shares Traded | Price | Shares Held |
|---|---|---|---|---|
| 5 Mar 2013 | Buy | 81,457 | $0.00 | 508,913 |
| 25 Jun 2012 | Buy | 25,000 | $4.20 | 427,456 |
| 28 Feb 2012 | Buy | 141,207 | $0.00 | 402,456 |
Institutional Holders
| % Shares Owned: | 78.69% |
| # of Holders: | 80 |
| Total Shares Held: | 25,787,803 |
| 3 Mo. Net Change: | 572,506 |
| # New Positions: | 21 |
| # Closed Positions: | 13 |
| # Increased Positions: | 44 |
| # Reduced Positions: | 27 |
| # Net Buyers: | 17 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Christopher Gleeson |
62 | 2011 | Chairman of the Board |
Hany Massarany |
50 | 2011 | President, Chief Executive Officer, Director |
Richard Slansky |
55 | 2012 | Chief Financial Officer |
Jon Kayyem |
48 | 2013 | Senior Vice President - Research and Development, Chief Scientific Officer |
Matthew Cohen |
40 | 2011 | Senior Vice President, General Counsel, Corporate Secretary |
Michael Gleeson |
37 | 2012 | Senior Vice President - Sales |
Jeffrey Hawkins |
34 | 2010 | Senior Vice President - Marketing and Business Development |
Jennifer Williams |
39 | 2010 | Senior Vice President - Global Operations & Human Resources |
Daryl Faulkner |
63 | 2010 | Independent Director |
James Fox |
2010 | Independent Director | |
Kevin O'Boyle |
57 | 2010 | Independent Director |
Stephen Worland |
53 | 2012 | Independent Director |

